HER2 Support Group Forums - View Single Post

Juls · 09-12-2015, 02:29 PM

The same goes for Health Boards here - why can't they negotiate cheaper prices?
It is a concern here as well - as UK Medicine Boards are cancelling or not approving drugs on cost basis. Just last week in England 3 cancer drugs cancelled (Eribulin,Lapatinib & Everolimus). I am in Scotland & currently in a Pertuzumab trial. Scottish Medicine Board has turned Pertuzumab down twice already. It is worrying to think that others may not get this drug purely on a cost basis!

Paul - Just wondering - Was Herceptin as expensive when first introduced? Is it still as expensive or has it reduced (in relative terms) because its the drug of choice for Her2? I don't know how drug companies work - but just wondering if Pertuzumab became standard treatment would price change?

09-12-2015, 02:29 PM	#7
Juls Senior Member Join Date: Mar 2014 Location: UK Posts: 563	Re: Pertuzumab not "cost effective"?! The same goes for Health Boards here - why can't they negotiate cheaper prices? It is a concern here as well - as UK Medicine Boards are cancelling or not approving drugs on cost basis. Just last week in England 3 cancer drugs cancelled (Eribulin,Lapatinib & Everolimus). I am in Scotland & currently in a Pertuzumab trial. Scottish Medicine Board has turned Pertuzumab down twice already. It is worrying to think that others may not get this drug purely on a cost basis! Paul - Just wondering - Was Herceptin as expensive when first introduced? Is it still as expensive or has it reduced (in relative terms) because its the drug of choice for Her2? I don't know how drug companies work - but just wondering if Pertuzumab became standard treatment would price change?